Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.84 USD | +2.44% | -3.67% | +64.71% |
05-06 | Oppenheimer Upgrades Chemomab Therapeutics to Outperform | MT |
04-10 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.71% | 11.65M | |
+9.99% | 114B | |
+12.01% | 107B | |
-3.07% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-6.90% | 17.51B | |
-39.36% | 17.17B | |
+5.82% | 14.14B | |
+33.05% | 12.2B |
- Stock Market
- Equities
- CMMB Stock
- News Chemomab Therapeutics Ltd.
- Chemomab Therapeutics Secures FDA Approval tor Phase 2 Trial of CM-101 for Systemic Sclerosis; Shares Climb